Amylyx Pharmaceuticals, Inc. (AMLX) Total liabilities 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) total liabilities at each fiscal year-end, per SEC filings.
$27.4MFY2025 · since FY2021: $17.4M → $27.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.4M | -5.1% |
| FY2024 | $28.9M | -65.6% |
| FY2023 | $84.0M | +65.2% |
| FY2022 | $50.8M | +191.7% |
| FY2021 | $17.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice